Advertisement
Research Article| Volume 14, ISSUE 2, P165-180, April 01, 1998

UROSEPSIS IN THE CRITICAL CARE UNIT

      This article will focus on some peculiar aspects of hospital-acquired bloodstream infection (BSI) originating in the urinary tract in critical care settings, particularly with respect to epidemiology and etiology. Pathogenetic and clinical features and diagnostic, therapeutic, and preventive measures of the septic process, with or without shock, which can follow a urinary tract infection (UTI), will then be discussed.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Al-Nawas B.
        • Krammer I.
        • Shah P.M.
        Procalcitonin in diagnosis of severe infections.
        Eur J Med Res. 1995/96; 1: 331-333
        • American College of Chest Physician/Society of Critical Care Medicine Consensus Conference Committee
        Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.
        Crit Care Med. 1992; 20: 864-874
        • Anonymous
        Nosocomial enterococci resistant to vancomycin—United States.
        MMWR. 1993; 42: 597-599
        • Archer G.L.
        • Climo M.W.
        Antimicrobial susceptibility of coagulase-negative staphylococci.
        Antimicrob Agents Chemother. 1994; 38: 2231-2237
        • Bartoloni A.
        • Colao M.G.
        • Orsi A.
        • et al.
        Comparative in vitro activity of meropenem against Italian isolates of gram-negative and gram-positive aerobic and gram-negative anaerobic bacteria.
        Rev Esp Quimioterap. 1992; 5: 49-52
        • Bartoloni A.
        • Stefani S.
        • Orsi A.
        • et al.
        High-level aminoglycoside resistance among enterococci isolated from blood cultures.
        J Antimicrob Chemother. 1992; 29: 729-731
        • Bartoloni A.
        • Stefani S.
        • Mantella A.
        • et al.
        High-level aminoglycoside resistance and glycopeptide resistance among enterococci isolated from blood cultures, 1990–1995.
        Clin Microbiol Infect. 1997; 3: 385-387
        • Beal A.L.
        • Cerra F.B.
        Multiple organ failure syndrome in the 1990s.
        JAMA. 1994; 271: 226-233
        • Beeson P.B.
        The case against the catheter.
        Am J Med. 1958; 24: 1-3
        • Blackwell T.S.
        • Christman J.W.
        Sepsis and cytokines: Current status.
        Br J Anaesth. 1996; 77: 110-117
        • Bone R.C.
        • Balk R.A.
        • Fein A.M.
        • et al.
        A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: Results of a prospective, multicenter, randomized, controlled trial.
        Crit Care Med. 1995; 23: 994-1005
        • Bryan C.S.
        • Reynolds K.L.
        Hospital-acquired bacteremic urinary tract infection: Epidemiology and outcome.
        J Urol. 1984; 132: 494-498
        • Bryan L.E.
        General mechanisms of resistance to antibiotics.
        J Antimicrob Chemother. 1988; 22: 1-15
        • Cannon J.G.
        Cytokines and shock.
        in: Cytokines and Inflammation. CRC Press, Boca Raton1991: 307-329
      1. Centers for Disease Control: National nosocomial infections study report. Annual Summary, October 1975.

        • Centers for Disease Control and Prevention
        Increase in national hospital discharge survey rates for septicemia—United States, 1979–1987.
        MMWR. 1990; 39: 31-34
        • Corti G.
        • Giganti E.
        • Paradisi F.
        • et al.
        Urinary tract infections in the city of Florence: Epidemiological considerations over a twenty-year period.
        Eur J Epidemiol. 1993; 9: 335-340
        • Corti G.
        • Giganti E.
        • Paradisi F.
        • et al.
        Susceptibility patterns of bacterial pathogens isolated from nosocomial urinary samples in Florence.
        in: Einhorn J. Nord C.E. Norrby S.R. Recent Advances in Chemotherapy. American Society for Microbiology, Washington1994: 340-341
        • Corti G.
        • Paradisi F.
        • Giganti E.
        • et al.
        Ciprofloxacin resistance in clinical isolates of Pseudomonas aeruginosa from Italian patients.
        Drugs. 1995; 49: 175-176
        • Cox C.E.
        Nosocomial urinary tract infections.
        Urology. 1988; 32: 210-215
        • Doebbeling B.N.
        • Stanley G.L.
        • Sheetz C.T.
        • et al.
        Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units.
        N Engl J Med. 1992; 327: 88-93
        • Dominguez-de Villota E.
        • Algora-Weber A.
        • Millan I.
        • et al.
        Early evaluation of coagulase negative staphylococcus in blood samples of intensive care unit patients: A clinically uncertain judgement.
        Intensive Care Med. 1987; 13: 390-394
        • Donowitz L.G.
        • Wenzel R.P.
        • Hoyt J.W.
        High risk of hospital-acquired infection in the ICU patient.
        Crit Care Med. 1982; 10: 355-357
        • Fisher C.J.
        • Dhainaut J.F.A.
        • Opal S.M.
        • et al.
        Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome.
        JAMA. 1994; 271: 1836-1843
        • Fisher C.J.
        • Opal S.M.
        • Dhainaut J.F.
        • et al.
        Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis.
        Crit Care Med. 1993; 21: 318-327
        • Galley H.F.
        • Webster N.R.
        The immuno-inflammatory cascade.
        Br J Anaesth. 1996; 77: 11-16
        • Garibaldi R.A.
        Hospital-acquired urinary tract infections.
        in: Prevention and Control of Nosocomial Infection. ed 2. Williams & Wilkins, Baltimore1993: 600-613
        • Garibaldi R.A.
        • Burke J.P.
        • Britt M.R.
        • et al.
        Meatal colonization and catheter-associated bacteriuria.
        N Engl J Med. 1980; 303: 316-318
        • Garibaldi R.A.
        • Mooney B.R.
        • Epstein B.J.
        • et al.
        An evaluation of daily bacteriologic monitoring to identify preventable episodes of catheter-associated urinary tract infection.
        Infect Control. 1982; 3: 466-470
        • Gorse G.J.
        • Messner R.L.
        • Stephens N.D.
        Association of malnutrition with nosocomial infection.
        Infect Control Hosp Epidemiol. 1989; 10: 194-203
        • Graham M.
        Frequency and duration of handwashing in an intensive care unit.
        Am J Infect Control. 1990; 18: 77-81
        • Haley R.W.
        • Culver D.H.
        • White J.W.
        • et al.
        The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals.
        Am J Epidemiol. 1985; 121: 182-205
        • Hartstein A.I.
        • Garber S.B.
        • Ward T.T.
        • et al.
        Nosocomial urinary tract infection: A prospective evaluation of 108 catheterized patients.
        Infect Control. 1981; 2: 380-386
        • Haug J.B.
        • Harthug S.
        • Kalager T.
        • et al.
        Bloodstream infections at a Norwegian university hospital, 1974–1979 and 1988–1989: Changing etiology, clinical features, and outcome.
        Clin Infect Dis. 1994; 19: 246-256
        • Jarvis W.R.
        • Edwards J.R.
        • Culver D.H.
        • et al.
        Nosocomial infection rates in adult and pediatric intensive care units in the United States.
        Am J Med. 1991; 91: 185S-191S
        • Jones R.N.
        • Kehrberg E.N.
        • Erwin M.E.
        • et al.
        Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States: I. Study on the threat of emerging resistances: Real or perceived?.
        Diagn Microbiol Infect Dis. 1994; 19: 203-215
        • Kass E.H.
        Asymptomatic infections of the urinary tract.
        Trans Assoc Am Physicians. 1956; 69: 56-64
        • Kaye D.
        • Hessen M.T.
        Infections associated with foreign bodies in the urinary tract.
        in: Bisno A.L. Waldvogel F.A. Infections Associated with Indwelling Medical Devices. ed 2. American Society for Microbiology, Washington1994: 291-307
        • Kelly M.T.
        • Roberts F.J.
        • Henry D.
        • et al.
        Clinical comparison of Isolator and BACTEC 660 resin media for blood culture.
        J Clin Microbiol. 1990; 28: 1925-1927
        • Kotilainen H.R.
        Prevention and control of nosocomial infection in the intensive care unit.
        in: Rippe J.M. Irwin R.S. Alpert J.S. Intensive Care Medicine. ed 2. Little, Brown, Boston1991: 827-838
        • Krieger J.N.
        • Kaiser D.L.
        • Wenzel R.P.
        Urinary tract etiology of bloodstream infections in hospitalized patients.
        J Infect Dis. 1983; 148: 57-62
        • Luce J.M.
        Introduction of new technology into critical care practice: A history of HA-1A human monoclonal antibody against endotoxin.
        Crit Care Med. 1993; 21: 1233-1241
        • Lynn W.A.
        • Cohen J.
        Adjunctive therapy for septic shock: A review of experimental approaches.
        Clin Infect Dis. 1995; 20: 143-158
        • Maki D.G.
        Nosocomial bacteremia: An epidemiological overview.
        Am J Med. 1981; 70: 719-732
        • Panlilio A.L.
        • Culver D.H.
        • Gaynes R.P.
        • et al.
        Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975–1991.
        Infect Control Hosp Epidemiol. 1992; 13: 582-586
        • Paradisi F.
        • Corti G.
        Once-daily dosing regimen for aminoglycoside plus betalactam combination therapy of serious lower respiratory tract infections.
        J Chemother. 1995; 7: 338-343
        • Parker S.E.
        • Davey P.G.
        Practicalities of once-daily aminoglycoside dosing.
        J Antimicrob Chemother. 1993; 31: 4-8
        • Parrillo J.E.
        Septic shock in humans: Advances in understanding of pathogenesis, cardiovascular dysfunction, and therapy.
        Ann Intern Med. 1990; 113: 227-242
        • Parrillo J.E.
        Pathogenetic mechanisms of septic shock.
        N Engl J Med. 1993; 328: 1471-1477
        • Pittet D.
        Nosocomial bloodstream infections.
        in: Prevention and Control of Nosocomial Infections. ed 2. Williams & Wilkins, Baltimore1993: 512-555
        • Pittet D.
        • Herwaldt R.A.
        • Massanari R.M.
        The intensive care unit.
        in: Brachman P.S. Bennett J.V. Hospital Infections. ed 3. Little, Brown, Boston1992: 405-439
        • Polastri F.
        • Aukenthaler R.
        • Loew F.
        • et al.
        Absence of significant bacteremia during urinary catheter manipulation in patients with chronic indwelling catheters.
        J Am Geriatr Soc. 1990; 38: 1203-1208
        • Rangel-Frausto M.
        • Pittet D.
        • Costigan M.
        • et al.
        The natural history of the systemic inflammatory response syndrome (SIRS).
        JAMA. 1995; 273: 117-123
        • Roberts S.D.
        • Resnick M.I.
        Urosepsis: The role of urologist.
        in: Roth R.K. Trunkey D.D. Sande M.A. New Surgical and Medical Approaches in Infectious Diseases (Contemporary Issues in Infectious Diseases, vol 6). Churchill-Livingstone, New York1987: 201-215
        • Schaberg D.R.
        • Culver D.H.
        • Gaynes R.P.
        Major trends in the microbial etiology of nosocomial infection.
        Am J Med. 1991; 91: 72S-75S
        • Schaeffer A.J.
        Catheter-associated bacteriuria.
        Urol Clin North Am. 1986; 13: 735-747
        • Scheckler W.E.
        • Scheibel W.
        • Kresge D.
        Temporal trends in septicemia in a community hospital.
        Am J Med. 1991; 91: 90S-94S
        • Senay H.
        • Goetz M.B.
        Epidemiologic of bacteremic urinary tract infections in chronically hospitalized elderly men.
        J Urol. 1991; 145: 1201-1204
        • Slotman G.J.
        • Fisher C.J.
        • Bone R.C.
        • et al.
        Detrimental effects of high-dose methylprednisolone sodium succinate on serum concentrations of hepatic and renal function indicators in severe sepsis and septic shock.
        Crit Care Med. 1993; 21: 191-195
        • Sullivan N.M.
        • Sutter V.L.
        • Mims M.M.
        • et al.
        Clinical aspects of bacteremia after manipulation of the genitourinary tract.
        J Infect Dis. 1973; 127: 49-55
        • Vincent J.-L.
        • Bihari D.J.
        • Suter P.M.
        • et al.
        The prevalence of nosocomial infection in intensive care units in Europe: Results of the European prevalence of infection in intensive care (EPIC) study.
        JAMA. 1995; 274: 639-644
        • Warren J.W.
        Nosocomial urinary tract infections.
        in: Mandell G.L. Bennett J.E. Dolin R. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, ed 4 (International Textbook of Infectious Disease, vol 2). Churchill-Livingstone, New York1995: 2607-2616
        • Wenzel R.P.
        • Pinsky M.R.
        • Ulevitch R.J.
        • et al.
        Current understanding of sepsis.
        Clin Infect Dis. 1996; 22: 407-412
        • Widmer A.F.
        Infection control and prevention strategies in the ICU.
        Intensive Care Med. 1994; 20: S7-S11
        • Wise R.
        • Andrews J.M.
        • Edwards L.J.
        In vitro activity of Bay-09867, a new quinolone derivative, compared with other antimicrobial agents.
        Antimicrob Agents Chemother. 1983; 23: 559-564
        • Young L.S.
        Sepsis syndrome.
        in: Mandell G.L. Bennett J.E. Dolin R. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, ed 4 (International Textbook of Infectious Disease, vol 1). Churchill-Livingstone, New York1995: 690-705